This vaccine is not ready
It will turn Russians into zombies
It will turn Russians into zombies
-
IP addresses are NOT logged in this forum so there's no point asking. Please note that this forum is full of homophobes, racists, lunatics, schizophrenics & absolute nut jobs with a smattering of geniuses, Chinese chauvinists, Moderate Muslims and last but not least a couple of "know-it-alls" constantly sprouting their dubious wisdom. If you believe that content generated by unsavory characters might cause you offense PLEASE LEAVE NOW! Sammyboy Admin and Staff are not responsible for your hurt feelings should you choose to read any of the content here. The OTHER forum is HERE so please stop asking.
(breaking!!!) russia is first to register covid vaccine! fuck china fuck usa fuck europe! all useless! putin is the best!
- Thread starter kaninabuchaojibye
- Start date
spot on. tested on dozens only...
best scammers, you mean.
seen my fair share of russian scammers.
nobody can trust russians. or russian federation.
wherever they go, they carry the same "virus" with them
you see
https://www.jpost.com/HEALTH-SCIENC...7YCArdBDTA0sp2jKcyVbaNQk2i4Uk5ROGmpjUM_tidbCk
Israeli scientists: 'In a few weeks, we will have coronavirus vaccine'
By MAAYAN JAFFE-HOFFMAN
APRIL 13, 2020 11:24
gone quiet since then.
many so called israelis are russkie and eastern euro squatters in palestine after all.
old habits, die hard.
stinkypura?
ever heard or seen stinkypura vaccine?
or stinkypura brand? or mnc?
or nobel laureate or fields medallist (all ang moh awards, and since stinkies worship ang mohs, let's use these metrics to decide how ang mohs pay stinkies back)?
or any other high fliers?
I wont be surprised chicom would test it on Urghur prisoners.
yup.
the kikes in palestine do the same
https://www.jpost.com/health-science/israeli-scientists-in-three-weeks-we-will-have-coronavirus-vaccine-619101
By MAAYAN JAFFE-HOFFMAN
APRIL 13, 2020 11:24
three weeks still haven't ended?
kikes sure know how to bullsh!t well.
malaysia should find volunteers from the chink population.
that includes stinky chinks of course.
malaysia on one side, indonesia on another.
nukes and mrbm/irbm cover by pakistan, dr m only needs to transfer 15 billion RM to Pakistan treasury/exchequer, game over.
China's coronavirus vaccine trials could deliver the goods — what does that mean for Australia?
More than a dozen enterprises in China have launched assembly lines to produce vaccines as of last month.(ABC News: GFX By Jarrod Fankhauser)
In the race for a viable coronavirus vaccine, China is one of the clear frontrunners.
Key points:
One vaccine under development by the pharmaceutical firm CanSino and the People's Liberation Army has already been cleared for use by the nation's military personnel.
But given the Chinese Communist Party-led nation's prickly foreign relations with many Western nations, including Australia, questions have been raised over what would happen if China were to become the first country to develop an effective vaccine.
Chinese President Xi Jinping says he won't limit which countries will be able to access their vaccines.(Xinhua Via AP: Ding Haitao)
Chinese President Xi Jinping has said his country's vaccines would be a "global public good" and would be made available to all nations.
However, questions have also been raised about the quality of Chinese-produced vaccines, in the face of multiple scandals in the country's vaccine manufacturing industry in the past decade.
Here's a look at the companies behind China's COVID-19 vaccine research, and how Australians might be affected by a vaccine that's made in China.
What do we know about China's vaccine trials?
There are 168 vaccine candidates that have started trials, according to World Health Organization data released this week.
Six of these are in phase 3 trials, meaning they are set to be tested on a large number of people to measure their effectiveness and safety.
Sinopharm has administered its vaccine to some 15,000 trial participants in the United Arab Emirates.(Xinhua Via AP)
Three of those vaccine candidates come from Chinese developers, including the state-owned enterprises Sinovac and Sinopharm, with the latter working on two trials in association with the Wuhan and Beijing Institutes of Biological Products.
COVID-19 vaccine development and research initially hit something of a roadblock in China — as case numbers fell, it became harder to test their vaccines through exposure to active cases of the virus.
This led Sinopharm to say back in June that its vaccine may not be ready before 2021.
However, the problem has since been solved by shifting the trial sites abroad.
Sinopharm has administered its vaccine to some 15,000 trial participants in the United Arab Emirates, according to company chairman Liu Jingzhen, who told state broadcaster CCTV they expected to finish phase 3 trials within about three months.
Sinovac is also taking a similar approach. The company launched its phase 3 trial with help from more than 1,600 participants in Indonesia, one month after a similar plan rolled out in Brazil with about 900 participants.
A total of 13 enterprises in China have launched assembly lines to produce vaccines as of last month, and Sinopharm has also built a production line for vaccines in Beijing.
In a statement released by Sinopharm, the Beijing facility was expected to be capable of producing 220 million doses a year.
Can we trust a Chinese vaccine?
Phase 3 trials see vaccines tested for their efficacy and safety on a large number of participants.(ABC News: Steve Wang)
There are concerns about the quality of Chinese vaccines, given a history of scandals there in the past.
An exposé nearly a decade ago revealed that four children were killed and 74 others harmed in Shanxi province after receiving vaccines that had been improperly stored.
This mistrust of the country's vaccine system was exacerbated following another scandal in 2016, when it was revealed tens of millions of dollars worth of expired vaccines had been sold around the country for years.
Hui Yang, an associate professor from Monash University, said there was no doubt Chinese vaccines would have to meet Australian standards before being imported.
However, Dr Yang said the problems in China's vaccine industry were more related to poor production and corruption, rather than the quality of the country's biomedical research.
"Factors such as false operation, corruption and mismanagement resulted in issues with the vaccine production."
The cold chain — a system for transporting and storing vaccines within the safe temperature range of 2 to 8 degrees Celsius — was the biggest challenge for proper vaccine management in China, alongside other issues like contamination.
"Each vaccine has a temperature criteria for storage and transportation. In Australia, we have a strict system to control these factors," Dr Yang said.
There are more than 200 coronavirus vaccine candidates worldwide.(AAP)
However, Richard Passeri from Mode Logistics, a Melbourne-based company that specialises in cold chain logistics from China, told the ABC he saw no issue with any vaccines arriving in Australia from abroad.
"Based on my experience in logistics, there are no safety issues in transporting vaccines from overseas," Mr Passeri said.
Mary-Louise McLaws, an advisor to the World Health Organization's COVID-19 response, said anxiety around Chinese vaccine production could be addressed by Chinese labs and producers collaborating with overseas virologists.
"Having an international group assisting China's production … provides that extra amount of trust in the final product," she said.
Would Australia benefit from a Chinese vaccine?
Professor McLaws said she believed there was little risk of China withholding any viable vaccine it developed from other countries, even those it disagreed with politically.
"If any country has the ability to produce something 24-7 and get it out into production, it's probably China," she said.
However, Dr Yang said Australians would potentially need to wait for a Chinese product, due to our troubled diplomatic relations with China.
"The diplomatic relationship is critical, because you will have to order vaccines first," Dr Yang said.
"It could be a strategic resource, which would not be possible to share with everyone for free … We've seen the face-mask economy a few months [ago], then we will see the vaccine economy instead."
Dr Yang said Australia had the most rigorous standards when it comes to vaccines, and people should be confident in the quality of our products.
Professor McLaws echoed Dr Yang's comment, adding that Australia shouldn't rush to buy up the first vaccine that makes it to market.
"I think it is good for the world to have all scientists try to identify a candidate that works well, because the one that gets to production first may not be the one that has the best response," she said.
Posted 3h
In the race for a viable coronavirus vaccine, China is one of the clear frontrunners.
Key points:
- Three of six vaccine candidates in phase 3 trials come from Chinese developers
- Xi Jinping has said his country's vaccines would be made available to all nations
- Chinese vaccines would have to meet strict Australian standards before being imported
One vaccine under development by the pharmaceutical firm CanSino and the People's Liberation Army has already been cleared for use by the nation's military personnel.
But given the Chinese Communist Party-led nation's prickly foreign relations with many Western nations, including Australia, questions have been raised over what would happen if China were to become the first country to develop an effective vaccine.
Chinese President Xi Jinping has said his country's vaccines would be a "global public good" and would be made available to all nations.
However, questions have also been raised about the quality of Chinese-produced vaccines, in the face of multiple scandals in the country's vaccine manufacturing industry in the past decade.
Here's a look at the companies behind China's COVID-19 vaccine research, and how Australians might be affected by a vaccine that's made in China.
What do we know about China's vaccine trials?
There are 168 vaccine candidates that have started trials, according to World Health Organization data released this week.
Six of these are in phase 3 trials, meaning they are set to be tested on a large number of people to measure their effectiveness and safety.
Three of those vaccine candidates come from Chinese developers, including the state-owned enterprises Sinovac and Sinopharm, with the latter working on two trials in association with the Wuhan and Beijing Institutes of Biological Products.
COVID-19 vaccine development and research initially hit something of a roadblock in China — as case numbers fell, it became harder to test their vaccines through exposure to active cases of the virus.
This led Sinopharm to say back in June that its vaccine may not be ready before 2021.
However, the problem has since been solved by shifting the trial sites abroad.
Sinopharm has administered its vaccine to some 15,000 trial participants in the United Arab Emirates, according to company chairman Liu Jingzhen, who told state broadcaster CCTV they expected to finish phase 3 trials within about three months.
Sinovac is also taking a similar approach. The company launched its phase 3 trial with help from more than 1,600 participants in Indonesia, one month after a similar plan rolled out in Brazil with about 900 participants.
A total of 13 enterprises in China have launched assembly lines to produce vaccines as of last month, and Sinopharm has also built a production line for vaccines in Beijing.
In a statement released by Sinopharm, the Beijing facility was expected to be capable of producing 220 million doses a year.
Can we trust a Chinese vaccine?
There are concerns about the quality of Chinese vaccines, given a history of scandals there in the past.
An exposé nearly a decade ago revealed that four children were killed and 74 others harmed in Shanxi province after receiving vaccines that had been improperly stored.
This mistrust of the country's vaccine system was exacerbated following another scandal in 2016, when it was revealed tens of millions of dollars worth of expired vaccines had been sold around the country for years.
Hui Yang, an associate professor from Monash University, said there was no doubt Chinese vaccines would have to meet Australian standards before being imported.
However, Dr Yang said the problems in China's vaccine industry were more related to poor production and corruption, rather than the quality of the country's biomedical research.
"Factors such as false operation, corruption and mismanagement resulted in issues with the vaccine production."
The cold chain — a system for transporting and storing vaccines within the safe temperature range of 2 to 8 degrees Celsius — was the biggest challenge for proper vaccine management in China, alongside other issues like contamination.
"Each vaccine has a temperature criteria for storage and transportation. In Australia, we have a strict system to control these factors," Dr Yang said.
However, Richard Passeri from Mode Logistics, a Melbourne-based company that specialises in cold chain logistics from China, told the ABC he saw no issue with any vaccines arriving in Australia from abroad.
"Based on my experience in logistics, there are no safety issues in transporting vaccines from overseas," Mr Passeri said.
Mary-Louise McLaws, an advisor to the World Health Organization's COVID-19 response, said anxiety around Chinese vaccine production could be addressed by Chinese labs and producers collaborating with overseas virologists.
"Having an international group assisting China's production … provides that extra amount of trust in the final product," she said.
Would Australia benefit from a Chinese vaccine?
Professor McLaws said she believed there was little risk of China withholding any viable vaccine it developed from other countries, even those it disagreed with politically.
"If any country has the ability to produce something 24-7 and get it out into production, it's probably China," she said.
However, Dr Yang said Australians would potentially need to wait for a Chinese product, due to our troubled diplomatic relations with China.
"The diplomatic relationship is critical, because you will have to order vaccines first," Dr Yang said.
"It could be a strategic resource, which would not be possible to share with everyone for free … We've seen the face-mask economy a few months [ago], then we will see the vaccine economy instead."
Dr Yang said Australia had the most rigorous standards when it comes to vaccines, and people should be confident in the quality of our products.
Professor McLaws echoed Dr Yang's comment, adding that Australia shouldn't rush to buy up the first vaccine that makes it to market.
"I think it is good for the world to have all scientists try to identify a candidate that works well, because the one that gets to production first may not be the one that has the best response," she said.
Posted 3h
Similar threads
